Merck zooms on reporting 14% rise in Q2 net

24 Jul 2012 Evaluate

Merck is currently trading at Rs. 614.90, up by 18.55 points or 3.11% from its previous closing of Rs. 596.35 on the BSE.

The scrip opened at Rs. 606.70 and has touched a high and low of Rs. 624.95 and Rs. 606.70 respectively. So far 3143 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 728.80 on 28-Jul-2011 and a 52 week low of Rs. 555.00 on 04-Jun-2012.

Last one week high and low of the scrip stood at Rs. 614.95 and Rs. 591.00 respectively. The current market cap of the company is Rs. 1020.86 crore.

The promoters holding in the company stood at 51.80% while Institutions and Non-Institutions held 21.53% and 26.66% respectively.

Merck has reported results for second quarter ended June 30, 2012.

On standalone basis, the company has posted a rise of 14.36% in its net profit at Rs 20.15 crore for the quarter ended June 30, 2012 as compared to Rs 17.62 crore for the same quarter in the previous year.  Total income has increased by 15.64% at Rs 185.32 crore for quarter under review as compared to Rs 160.26 crore for the quarter ended June 30, 2011.

Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.

Procter&Gamble Healt Share Price

5450.35 -54.55 (-0.99%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.